(Q38053198)

27 August 2017

title

Intravitreal injections: a review of the evidence for best practice (English)

1 reference

27 August 2017

1 reference

Xavier J Fagan

1

1 reference

27 August 2017

Salmaan Al-Qureshi

series ordinal

2

1 reference

27 August 2017

language of work or name

1 reference

1 July 2013

1 reference

Clinical and Experimental Ophthalmology

27 August 2017

published in

1 reference

27 August 2017

volume

41

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

500-507

1 reference

Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection

27 August 2017

cites work

1 reference

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials

21 January 2018

1 reference

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application

21 January 2018

1 reference

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

21 January 2018

1 reference

Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections

21 January 2018

1 reference

Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting

21 January 2018

1 reference

Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

21 January 2018

1 reference

Severe neurological complications after central neuraxial blockades in Sweden 1990-1999.

21 January 2018

1 reference

Randomized trial of anesthetic methods for intravitreal injections

21 January 2018

1 reference

Comparison of topical anesthetics for intravitreal injections : a randomized clinical trial

21 January 2018

1 reference

Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anesthesia in cataract surgery: a randomized controlled trial.

21 January 2018

1 reference

Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival

21 January 2018

1 reference

Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis.

21 January 2018

1 reference

Anesthesia for intravitreal injection

21 January 2018

1 reference

SCORE Study report 3: study design and baseline characteristics

21 January 2018

1 reference

Prophylaxis of Endophthalmitis with Topical Povidone-iodine

21 January 2018

1 reference

Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery

21 January 2018

1 reference

Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis

21 January 2018

1 reference

Experimental evaluation of chlorhexidine gluconate for ocular antisepsis

21 January 2018

1 reference

Defining the normal bacterial flora of the oral cavity

21 January 2018

1 reference

Bacterial dispersal associated with speech in the setting of intravitreous injections.

21 January 2018

1 reference

The use of surgical facemasks during cataract surgery: is it necessary?

21 January 2018

1 reference

Surgical hand antisepsis to reduce surgical site infection

21 January 2018

1 reference

Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial

21 January 2018

1 reference

Hand hygiene in the dermatologist's office: to wash or to rub?

21 January 2018

1 reference

Evolving guidelines for intravitreous injections

21 January 2018

1 reference

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

21 January 2018

1 reference

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits

21 January 2018

1 reference

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

21 January 2018

1 reference

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

Acute endophthalmitis following intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment

21 January 2018

1 reference

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery

21 January 2018

1 reference

A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.

21 January 2018

1 reference

Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis

21 January 2018

1 reference

Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection

21 January 2018

1 reference

Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEO.12026

1 reference

27 August 2017

1 reference